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Basement membranes (BMs) are highly specialised extracellular matrix (ECM) structures
that within the heart underlie endothelial cells (ECs) and surround cardiomyocytes and vas-
cular smooth muscle cells. They generate a dynamic and structurally supportive environ-
ment throughout cardiac development and maturation by providing physical anchorage to
the underlying interstitium, structural support to the tissue, and by influencing cell behaviour
and signalling. While this provides a strong link between BM dysfunction and cardiac dis-
ease, the role of the BM in cardiac biology remains under-researched and our understanding
regarding the mechanistic interplay between BM defects and their morphological and func-
tional consequences remain important knowledge-gaps. In this review, we bring together
emerging understanding of BM defects within the heart including in common cardiovascu-
lar pathologies such as contractile dysfunction and highlight some key questions that are
now ready to be addressed.
Introduction
Basement membranes (BMs) are thin, sheet-like structures of the extracellular matrix (ECM) which serve
as a barrier and anchorage point between the cell and interstitial ECM, and can influence cell differen-
tiation, signalling, and migration in the vast majority of tissues [1]. Within the heart, BMs underlie the
endothelial cells (ECs) and surround cardiomyocytes and vascular smooth muscle cells (Figure 1A). To
date, relatively little is understood about the precise role of BMs in the heart. There is fragmentary knowl-
edge throughout the literature from studies which have investigated BM components in isolation and
how their absence affects cardiac development. Various animal models have been instrumental in under-
standing the distribution and temporal relationship between BM components and cardiac development.
However, as these models often reflect multisystem disorders and/or are embryonic lethal, investigating
adult cardiac function is often limited and mechanistic insight remains poor. For hereditary diseases af-
fecting the BM, this knowledge is even more limited with the extent of cardiac involvement often being
overlooked and the mechanisms which drive any pathologies almost completely unknown. In recent years,
links between common cardiovascular pathologies and BM dysfunction have become more apparent and
have suggested the importance of BMs in cardiac biology. However, significant gaps remain in our under-
standing, which if addressed, would shed light on how these pathologies develop and progress, and would
reveal novel therapeutic targets. In this review, we summarise our current understanding of cardiac BMs
and highlight questions which require further investigation and represent unexplored research avenues.
General concepts of structure and functions of BMs
BMs have a wide array of biological functions, occur in almost all tissues, and underlie multiple cell types
including epithelial and ECs, adipocytes, and myocytes. This physical demarcation compartmentalises
tissues and cell types from one another (Figure 1A). BMs are crucial throughout embryonic development
and tissue formation as they trigger and maintain cellular polarity [2]. They provide structural and me-
chanical support to tissues as BMs serve as an anchorage point between cells and the underlying interstitial
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Figure 1. BMs within the heart
(A) The ECM in the heart consists of BM and interstitial matrix that contains the fibrillar collagens (e.g. collagen I, III etc). BM
(light blue) surrounds cardiomyocytes and microvasculature. Interspersed within the ECM are cardiac fibroblasts (brown) which are
responsible for the secretion of many matrix components. (B) Magnified view of the BM as an interface between the interstitial matrix
and cardiomyocyte sarcolemma. Various BM components interact with the cardiomyocyte sarcolemma via integrin, dystroglycan,
and DDR receptors. Within the BM, laminin and collagen IV networks are assembled with perlecan and nidogen acting as ‘bridging
molecules’ between these networks. Collagen XV and XVIII display their characteristic polarisation, linking the BM with the interstitial
matrix. Collagen VI microfibrils interact with collagen IV, providing a physical link between the BM and fibrillar components of the
interstitial matrix. For clarity, the lateral aggregation of collagen type IV is not shown and only limited examples of BM components
and their interactions are represented. Abbreviation: DDR, discoidin domain receptor.
ECM through various cellular interactions, and they also act as a reservoir for growth factors (Figure 1) [1,3]. For a
more detailed overview on general BM function and biology, we refer the reader to a recent excellent review [4].
BMs generally comprise proteoglycans and glycoproteins with the primary components being type IV collagens,
laminins, perlecan, and nidogens [5–10]. The composition and complexity of individual BMs is dependent on the tis-
sue and cell type that they surround or underlie [11]. This compositional heterogeneity results in diverse cell–matrix
interactions and multiple biological functions tailored to their location. Recent elegant single cell RNA sequencing
analysis revealed that within the heart, different cell populations including cardiomyocytes, cardiac fibroblasts, vas-
cular smooth muscle cells, and ECs contribute to the production of cardiac BM components [12]. Recent data from
Drosophila development showed diffusive properties of some BM components and that components can be secreted
and deposited by cells that do not reside on the BM [13]. This is also supported by elegant data from Caenorhabditis
elegans where tagging of endogenous BM components revealed that some components, such as laminin and collagen
type IV, form stable scaffolds within the BM while other components remain mobile, facilitating dynamic changes in
BM composition over time [14]. It should, therefore, be noted that individual BM components expressed by a par-
ticular cell type could be incorporated into one or multiple BMs within the heart. The complexity and heterogeneity
of cardiac BMs will require further in-depth assessment to understand how their composition relates to function.
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Figure 2. Major BM components of the heart
(A) Protein domain structure of collagen type IV. Each α chain consists of a large central collagenous domain flanked by a N-terminal
7S domain and a C-terminal non-collagenous NC1 domain. (B) Collagen type XVIII (C) Collagen type XV. Collagen types XVIII and
XV are structurally very similar, but vary in their glycosaminoglycan side chain composition with collagen XVIII binding heparan
sulphate chains and collagen XV predominantly chondroitin sulphate chains. The collagenous domain of collagen type XVIII is
flanked by a NC1 domain at the C-terminus which contains a trimerisation domain, a hinge region, and an endostatin peptide. (D)
Collagen type VI α1(VI) and α2(VI) chains comprise a short triple helical collagenous domain flanked by globular N-terminal and
C-terminal domains, with the C-terminal consisting of two von Willebrand factor type A domains. The α3(VI), α4(VI), α5(VI), and
α6(VI) chains are structurally homologous. However, their N-terminus and C-terminus are larger and more variable than that of α1(VI)
and α2(VI). (E) Laminin isoforms expressed within the heart. All laminin isoforms contain an α, β, and γ chain that interact to form the
coiled coil domain with each chain providing the arm of the cruciform shape. Laminin proteins interact via their N-terminal domains
(LN) to enable laminin network formation. The C-terminal of the laminin α chain contains five globular domains (LG) that mediate
interactions with cell surface receptors such as integrin and dystroglycan receptors. Laminin isoforms that contain the shorter
laminin α4 do not exhibit the traditional cruciform structure. Nidogen-binding sites are also indicated. (F) Protein domain structure
of perlecan. Perlecan has five domains; Domain I at the N-terminal which contains a SEA (sperm protein, enterokinase, agrin) region
and binds glycosaminoglycan chains. Domain II is structurally homologous to the low-density lipoprotein (LDL) receptor. Domain III
contains laminin domain IV regions interspersed with epidermal growth factor repeats. Domain IV contains Ig like repeats. Similar
to domain III, domain V contains laminin globular domains interspersed with epidermal growth factor repeats. BM components and
cell membrane receptors that bind the different domains are also provided. (G) Protein domain structure of nidogen 1 and 2. The
three globular domains of nidogen are linked by a thin and thick rod like domains. Other BM components such as collagen type IV,
perlecan, and laminin bind the globular domains allowing for nidogen to act as a ‘bridging’ molecule between the BM networks.
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Revolutionary single cell RNA sequencing data of the adult heart have been compiled and are now readily accessible
in various atlas formats [15,16]. In combination with proteomics and immunostaining data, these tools offer an in-
credibly useful resource that could be utilised to provide some overview regarding the composition of the different
BMs within the heart and the putative cellular origin of several BM components within the heart.
BM components in the heart
In this section, we will give a brief overview of the major BM components expressed within the heart and those in
which an associated cardiac phenotype has been reported.
BM collagens
Vertebrate genomes encode 28 types of collagen that vary in composition and biological activity [17], and have been
divided into types based on their protein domain and supramolecular structures [18]. For this review, we will not
cover all BM collagens but will focus on those for which a role in heart biology has been documented.
Collagen IV
Several collagens are localised specifically to BMs with the most abundant structural component of BMs being col-
lagen type IV [19,20]. For more in-depth reviews on collagen IV and its role in human disease, we refer the reader to
[21,22]. Briefly, collagen IV is a non-fibrillar, network-forming collagen, and vertebrates have six genes, COL4A1–6,
each encoding its own α chain α1–α6(IV). In contrast with fibrillar collagens like collagen I, II, III and V, collagen
IV contains interruptions to the Gly–Xaa–Yaa sequence in its collagenous domain (Figure 2A) [23]. These inter-
ruptions increase flexibility of the protomer and network, and can aid in specific heterotrimer interaction as well
as increasing the aggregation propensity of the protein [24]. In the endoplasmic reticulum (ER), the α chains are
extensively post-translationally modified hydroxylation, glycosylation and galactosylation [25]. Three α chains inter-
act through their NC1 domains in specific combinations to produce three heterotrimeric protomers; α1.α1.α2(IV),
α3.α4.α5(IV), and α5.α5.α6(IV). This is followed by triple helix formation in a zipper-like fashion in a C-terminal
to N-terminal direction. Collagen IV protomers are then secreted from the cell and incorporated into the ECM [26].
In the BM, the 7S and NC1 domains are vital in forming the three-dimensional collagen IV network as the NC1
domains of two protomers interact to form dimers, and the 7S domains of four protomers to form tetramers (Figure
1B and Figure 2A). Combined this leads to the generation of a lattice style network [27]. The α1.α1.α2(IV) is the
predominant isoform throughout development and in the majority of adult tissues, including the heart [28].
Collagen type XV and XVIII
Collagen XVIII and XV are proteoglycans and belong to the family of multiplexin collagens that contain multiple
triple helical collagenous domains interspersed with interrupting non-collagenous domains [18]. Similar to collagen
IV, the interrupted nature of the collagenous domains of collagen XV and collagen XVIII provides increased flexibil-
ity compared with fibrillar collagens (Figure 2B-C) [29,30]. Collagen XVIII contributes to the structural integrity of
the BM due to its polarised orientation within the BM [30] whereby its N-terminal end extends into the sublamina
densa, where it interacts with the fibrillar structures of the interstitial matrix (Figure 1B) [31]. The endostatin pep-
tide contained within the NC1 domain is involved in the interaction of collagen XVIII with other BM components
such as laminins and perlecan, and has received much attention for its reported effects on angiogenesis (Figure 2B-C)
[31,32]. These three BM collagens contain cryptic biologically active polypeptide fragments, called matrikines, that
are released following proteolytic cleavage in the ECM. Some of these have anti-angiogenic properties which is not
shared by the parental, uncleaved molecule. For collagen IV angiogenic inhibitors derived from the NC1 domain in-
clude arresten (α1(IV)), canstatin (α2(IV)) and tumstatin (α3(IV)) [33]. Endostatin is liberated following proteolytic
cleavage of the hinge region of Collagen XVIII (Figure 2B) [34], while the structurally similar C-terminal region of
collagen XV (Figure 2C) contains the restin or endostatin-XV peptide [35].
Collagen type VI
Collagen type VI is encoded by six different genes (COL6A1–A6) each encoding a respective α chain (Figure
2D) [36,37]. Collagen VI is unique in its structure and assembly as the α chains interact in a α1(VI), α2(VI),
α3/α4/α5/α6(VI) pattern to form a heterotrimeric protomer [38,39]. These protomers form dimers, and finally
tetramers within the ER before being secreted into the BM where they form microfilaments [40]. This complex struc-
ture and assembly allows Collagen VI to interact with a variety of cell membrane receptors, interstitial matrix collagens
and BM components, specifically collagen IV (Figure 1B) [41].
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Laminins
Laminins are, besides collagen IV, the other major network forming component of BMs (Figure 1B). The molecu-
lar structure of laminin and interactions with other BM components have been extensively described and for more
in-depth reviews, please see [42,43]. The initial characterisation of laminins by Timpl and colleagues was fundamen-
tal in the initiation of BM research and was pivotal in our understanding of BM structure and biology [42,44–48].
To date, 16 laminin isoforms have been identified in vertebrates whereby each laminin molecule comprises an α, β,
and γ chain (Figure 2E). However, within the heart the major isoforms expressed are LM-211, 221, 411, 421, 511,
and 521 (Figure 2E). There are five α, three β, and three γ chains and each is encoded by an individual gene [49].
Most laminins are folded into cross-shaped heterotrimers, although truncated T-shaped laminins also occur (Figure
2E). The laminin amino-terminal (LN) domains on the short arms of the α, β, and γ chains are essential for laminin
network polymerisation and self-assembly within the BM as well as interaction with other BM components such as
nidogen (Figure 1B) [42,50,51]. The C-terminus of theα chain contains five globular LG domains that are responsible
for mediating cell–matrix interactions (Figure 1B and Figure 2E) [52].
Perlecan
Perlecan is an multidomain heparan sulphate proteoglycan which is expressed throughout embryonic development,
particularly during the vascularisation of embryonic tissues and the developing skeletal system [53–56]. This large
proteoglycan has five distinct domains that interact with other BM components and cell receptors to mediate cell
adhesion and angiogenic activity (Figure 2F) [57]. Experiments in Drosophila demonstrated that perlecan deposi-
tion in BMs is dependent on collagen IV [13,58,59]. Once incorporated, perlecan can bind other BM components,
i.e. collagen IV, nidogen, and laminin, to provide BM assembly and stability (Figure 1B) [46,60,61]. Perlecan also
binds integrin receptors as it contains laminin-like domains interspersed with epidermal growth factor repeats that
enable EC adhesion [62,63]. Finally, in addition to integrin binding, it interacts with dystroglycan receptors via its
laminin-like globular domains [64]. The core protein and heparan sulphate side chains of perlecan sequester growth
factors such as fibroblast growth factor-2 (FGF2), vascular endothelial growth factor (VEGF) and platelet-derived
growth factor (PDGF) [65,66], ensuring a key role in mediating growth factor signalling.
Nidogens
Nidogens, also referred to as entactins, are sulphated glycoproteins (Figure 2G) and vertebrates encode two nidogens,
nidogen 1 and nidogen 2 that contain binding sites for laminin, collagen IV, and other proteoglycans including per-
lecan [67,68]. Similar to perlecan, based on binding other BM components, including collagen IV and laminins in
vitro, nidogen is proposed to serve as ‘bridging molecules’ between collagen and laminin networks in BMs (Figure
1B). Recent work in Drosophila highlighted that the contribution of nidogen to coupling the collagen IV and laminin
network, and BM assembly and stability varies between tissues [69]. Therefore, the exact nature of these interactions
and the role of nidogen in BM assembly and stability in vivo remains to be fully determined.
Impact of BM disruption on cardiac development
To understand the role of BM in cardiac development, many studies have investigated effects of mutations in various
BM components and how morphological changes to the BM during cardiac development translates into structural
abnormalities in the embryonic heart. Based on these studies, the BM has been implicated in various key stages of
cardiac development including cardiomyocyte differentiation and homeostasis, cardiac morphogenesis, endocardial
cushion and atrioventricular valve development, stability of the microvasculature and angiogenesis. We refer the
reader to several excellent recent reviews, which describe cardiac development events and the roles of ECM compo-
nents during these processes in extensive detail [70–73]. Here, we will discuss the roles of BM components on cardiac
morphogenesis that have been investigated in various transgenic models.
Cardiomyocyte differentiation and homeostasis
Cardiogenesis relies on intracellular signalling to induce cardiomyocyte differentiation and activation of
cardiac-specific gene expression within cardiac progenitor cells (CPCs). BM components such as laminins and col-
lagen type IV localise to the CPC ECM niche in the developing mouse and human heart [74]. Specifically, in vitro
three-dimensional models enriched for collagen type IV show increased incorporation of murine CPCs but the func-
tional relationship and mechanisms which contribute to this expansion remain unclear [74]. Several laminin isoforms
are differentially expressed regionally and throughout developmental stages. Laminin α1β1γ1 (LM-111) is the most
widely expressed isoform throughout embryonic development. The role of the γ1 subunit on the differentiation and
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Table 1 Summary of various murine knockout models of BM components and the observed cardiac phenotypes
Model Cardiac phenotypes observed References
Lama4−/− mouse - Rupture and dilation of the coronary microvasculature
- Cardiac haemorrhage
- Focal regions of fibrosis
- Cardiomyocyte death
[113,115]
Col4a1/Col4a2 double null mouse - Cardiac haemorrhage
- Bleeding within pericardium
- Dilation of blood vessels
[28]
Col4a2em1(IMPC )Wts mouse (homozygous knockout) - Double outlet right ventricle
- Ventricular septal defects
- Malformations of the great intrathoracic arteries
- Abnormal regions of tissue development
[94]
Col18a1−/− mouse - Increased coronary vascular permeability and
neovascularisation
[91]
Col15a1−/− mouse - Increased myocardial stiffness
- Cardiomyocyte disorganisation
- Myocardial capillary rupture
- Increased coronary vascular permeability and
narrowing
- Decreased juvenile LV function
[125,174]
Col6a1−/− mouse - Improved cardiac function and reduced remodelling
following MI
[182]
Perlecan−/− mouse - Myocardial clefting
- Cardiac haemorrhage
- Bleeding within pericardium
- Pericardial thickening
- Transposition of the great arteries
- Hyperplastic conotruncal endocardial cushions
[54,107,127]
Nid1/Nid2 double null - Myocardial clefting
- Cardiac haemorrhage
- Trabecular hypoplasia
- Mild reduction in myocardial compaction
[84]
functionality of cardiomyocytes has been investigated in vitro using LAMC1 knock-out murine embryonic stem
cell-derived cardiomyocytes. Surprisingly, sarcomeric arrangement was not affected in these cardiomyocytes despite
a lack of a BM, which suggests that although laminin deposition correlated with sarcomere development, function-
ally it may not have a direct role [75–77]. Recent in vitro work suggested LM-511/521 as a driver of cardiomyocyte
differentiation from pluripotent stem cell-derived cardiomyocytes [78]. However, it remains to be determined if this
mechanism also influences in vivo cardiomyocyte maturation.
Determining cardiac morphology
The morphological events involved in cardiac development are dependent on cell migration, differentiation, cavita-
tion, apoptosis, cell–cell interactions, and cell fusion [79]. Many of these rely on ECM remodelling and so it is vital
to understand how the BM is specifically involved in the regulation of these events, as their disruption often leads to
congenital heart defects.
Perlecan expression is particularly prominent during the early stages of cardiovascular development [53], which is
reflected with Perlecan (Hspg2−/−)-deficient mouse embryos displaying severe cardiac abnormalities at ∼10.5 dpc
associated with embryonic lethality at this timepoint. Clefts formed in the myocardium and blood can no longer be
contained within the ventricles and leaks into the pericardium, resulting in cardiac arrest (Table 1) [54,80]. Ultra-
structural analysis revealed defective BMs with decreased incorporation of other BM structural components, lead-
ing to cardiomyocytes where the BM was disrupted and rudimentary, or completely absent. These findings indicate
that perlecan is necessary to maintain the structural integrity of the BM and myocardium under mechanical stress.
Mouse models have also been employed to investigate the role of nidogen. While the hearts and BM of nidogen 1
(Nid1−/−)-deficient mice generally appear normal due to a compensatory effect of nidogen 2 [81,82], complete nido-
gen deficiency in Nid1−/− Nid2−/− mice leads to death shortly after birth with lung and heart defects whereby some
of the hearts were dilated [83]. Reduction in trabeculation and compaction of the ventricular wall was also observed,
which led to cleft formation and intramyocardial haemorrhage, similar to that of perlecan-deficient mice albeit at a
later stage (Table 1) [84]. However, the severity of this phenotype was variable and ranged from a slight reduction in
compaction to complete separation of myocardial muscle fibres [84].
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Endocardial cushion and atrioventricular valve development
Endocardial cushions serve as the sites of atrioventricular valve and septa formation, and deviation of the aortic and
pulmonary outflow tracts. This septation continues during development resulting in the four chambered heart struc-
ture while ensuring directional blood flow that by-passes the pulmonary circulation in utero via foetal shunts such
as the foramen ovale, ductus arteriosus, and ductus venosus [85]. Within the developing mouse heart, collagen XVIII
is primarily localised to the vasculature and endocardial cushions [86,87]. This expression is closely associated with
the migrating mesenchymal cells during valve leaflet formation with Col18a1−/− mice displaying ultrastructural al-
terations of the BM surrounding the valve leaflets (Table 1) [88]. Nonsense mutations in the gene COL18A1, which
encodes the collagen XVIII α chain, causes the clinically and genetically variable disorder Knobloch syndrome [89].
Knobloch syndrome patients develop severe ocular and cranial malformations such as myopia, retinal detachment
and occipital encephalocele, but hypertriglyceridaemia and renal fibrosis have also been reported [31,90,91]. How-
ever, Knobloch is characterised by variable expressivity whereby the clinical features vary between patients [92]. For
example, there has been a case report of a patient diagnosed with Knobloch syndrome presenting with a ventricular
septal defect in addition to other features of the disorder [93]. Thus, while heart defects are not a major feature of
Knobloch syndrome, these mutations may interfere with cardiac development in some cases. This variable disease
expressivity could be due to genetic and environmental modifiers but to date there has been no analysis reported on
these.
A role for collagen IV in cardiac development has also recently been described through the generation of a new
Col4a2-deficient mouse model. Near absence of Col4a2 in Col4a2em1(IMPC)Wts mice causes embryonic lethality
post-organogenesis with extensive cardiovascular defects including double outlet right ventricle, atrial and ventric-
ular septal defects, and various vascular malformations (Table 1) [94]. The delayed onset of embryonic lethality and
milder defects compared with Col4a1−/− Col4a2−/− mice may be due to some residual Col4a2 mRNA production
[94]. Importantly, a role for collagen IV in heart development is also supported by case studies of patients with dele-
tions of regions of chromosome 13 that include COL4A1 and COL4A2 that developed congenital heart defects in-
cluding double outlet right ventricle, pulmonary stenosis, and both atrial and ventricular septal defects. This suggests
COL4A1 and COL4A2 are candidate genes for congenital heart defects stemming from impaired endocardial cush-
ion development (Table 2) [95–97], as supported by the data from the Col4a2em1(IMPC)Wts mouse [94]. Hereditary
angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC) syndrome patients with COL4A1 glycine
substitution mutations can develop mitral/aortic valve prolapse, with some requiring artificial valve replacement later
in life (Table 2) [98–100]. A recent case study of a patient with a de novo glycine to glutamic acid mutation in the
COL4A1 gene was diagnosed with mitral valve regurgitation and the presence of an abnormal muscle bundle which
obstructed outflow from the left ventricle upon echocardiogram assessment (Table 2) [101]. The data from mouse
models and patients support that the reduction in extracellular collagen IV causes congenital heart defects affecting
endocardial cushion formation, but the mechanisms for the adult phenotypes remain unclear.
Mitral valve insufficiency and atresia have also been recorded in patients with LAMA5 and LAMB2 mutations
[102,103]. Interestingly, a patient case study report of cardiac phenotypes associated with a LAMB2 mutation also
included hypoplastic left ventricle and double outlet right ventricle [103].
In early human cardiac development (week 5) collagen VI expression is localised to the endocardial cushion mes-
enchyme and is sparse throughout the developing myocardium [104]. As development continues, the expression at
the endocardial cushions is more prominent and observed in the forming atrioventricular valve leaflets [104]. By
week 11, expression is more intense in the subendocardial layer of the ventricles and atria [104]. Based on data from
trisomy 21 patients, it has been proposed that overexpression of COL6A1/2 is implicated in the development of con-
genital heart defects involving endocardial cushion-derived structures such as atrioventricular septal defects [104].
However, the underlying mechanisms remain unknown.
Perlecan-null mice also develop congenital heart defects including transposition of the great arteries (TGA) (Table
1) [105], whereby the connection of the arteries is switched and the thoracic aorta outlets from the right ventricle
and the pulmonary artery from the left ventricle. TGA is often associated with other cardiac malformations such as
ventricular septal defects, left ventricular outflow tract obstruction, pulmonary stenosis, and coarctation of the aorta.
The majority of newborns with the TGA present clinically with cyanosis, however the severity is dependent on the
extent of intercirculatory mixing and other cardiac pathologies [106]. In perlecan-deficient mice this developmental
defect is associated with an increase in the cardiac mesenchyme, which forms the endocardial cushions, that leads to
impaired rotation of the developing outflow tract and septation of the aortic and pulmonary artery [107].
Finally, mutations in NID1 and LAMC1 have been associated with a variety of severe congenital malformations,
which are collectively referred to as Dandy–Walker syndrome [108]. This condition can result in variable cerebellar
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COL4A1 p.P352L Aortic valve insufficiency [121]
p.G498D, p.G498V, p.G510R, p.G525L,
p.G528D, p.G624X
Supraventricular arrhythmia [119,99,188]
p.G749S, p.G618E Mitral valve prolapse/regurgitation [101,117,100]
p.E1615K Atrioventricular septal defects [96,97]
p.G148E, p.G209S, p.G696C Foetal arrhythmia/abnormal
cardiotocography
[189]
p.G618E Obstructive hypertrophic cardiomyopathy [101]
13q33.3q34 deletion Double outlet right ventricle [95]




COL18A1 ND Ventricular septal defect [93]
COL6A1 ND (UCMD) Cardiac arrhythmia [191]
ND (Bethlem myopathy) Progressive left ventricular dysfunction in
pregnancy
[181]
Trisomy 21 Various atrioventricular septal defects [104]
LAMA2 p.T821P, p.C1469R, p.R1549X Dilated cardiomyopathy [148,147]
p.H2627G, p.R1844S, Palpitations [190]
p.R1350X Mitral regurgitation [190]
p.T821P, p.C1469R, p.R1549X, Conduction defects [147,148]
p.H2627G, p.R1029fs Myocardial wall hypokinesia [190]
LAMA4 p.D879H Hypoplastic left heart syndrome [146]
p.D1309N Infantile dilated cardiomyopathy [146]
p.P943L, p.R1073X Severe adult dilated cardiomyopathy [145]
LAMA5 p.V3140M Mild mitral valve insufficiency [102]
LAMB2 p.R1539G Double outlet right ventricle




LAMC1/NID1 ND AV canal defects
Atrial and ventricular septal defects
Pulmonary stenosis
[108]
The vast majority of these cardiac phenotypes have been established through imaging techniques such as echocardiography. In patient case re-
ports/summaries of disease phenotypes, cardiac involvement is often not reported or not described in detail. ND, mutation information not described.
hypoplasia, meningeal anomalies, and occipital skull defects. However, an analysis of 148 cases identified various car-
diac defects in 16.7% of these cases, all of which stem from impaired endocardial cushion development, i.e. atrial and
ventricular septal defects and pulmonary stenosis [109]. However, little is known regarding the mechanism of NID1
and LAMC1 mutations and how they lead to the congenital heart defects in a subset of Dandy–Walker syndrome
patients.
Structural integrity of microvasculature and angiogenesis
Coronary vascularisation takes place following the compaction of the myocardium that produces trabeculae which are
thick column-like ridges of myocardial tissue [110]. The deposition of BM components, as confirmed by immunolo-
calisation within the rat heart, precedes vessel tube formation, which suggests that the BM organisation provides a
scaffold for the newly formed myocardial vessels [111]. Gene expression analysis revealed that the most abundant
laminin network within the heart consists of LM-211 and LM-221 [112]. LM-511 and LM-521 isoforms are also
expressed and are primarily within the larger coronary vessels [113,114]. Other laminins that are highly expressed
during cardiac and muscle tissue development are LM-411 and LM-421 [47], suggesting a key role for laminin α4.
Lama4 knock-out mice progress through development, with the majority surviving birth. However, mutant mice
display rupture and dilation primarily affecting the microvasculature which led to haemorrhaging throughout the
embryo, including the heart (Table 1) [113]. This microvascular disease leads to hypertrophic cardiomyopathy asso-
ciated with focal regions of fibrosis and cardiomyocyte death [115].
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Monogenic COL4A1 syndrome due to mutations in COL4A1 or COL4A2 is a complex multisystemic disorder
that includes ocular defects, intracerebral haemorrhage, cerebral small vessel disease, kidney disease, and muscle
cramps [10,20–22,99,116–121]. While laminins have been implicated in the primary organisation of the cardiac BM
in Drosophila and are critical for initial BM development, collagen IV is required to provide stability to newly ar-
ranged BMs [10,28,122,123]. Despite the detrimental effects on cardiovascular and cerebrovascular development in
collagen IV-deficient mouse embryos, collagen IV is not required for establishing BMs in the developing embryo [28].
However, in mice, the absence of collagen IV causes the BMs to be rudimentary in nature without a consistent ar-
rangement and they do not fully surround the cardiomyocyte perimeter (Table 1) [28]. Similar to the lama4−/− mice,
and perhaps not surprising given intracerebral haemorrhage due to COL4A1 or COL4A2 mutations, Col4a1−/−
Col4a2−/− mice display bleeding from the heart and vascular defects which are thought to be due to vascular fragility
driven by decreased BM stability and defective cell–cell contacts [28].
Collagen XV is highly expressed within the vasculature and musculature of cardiac and skeletal muscle [124–126].
In contrast with many knock-out mouse models of BM components, Col15a1−/− mice are viable [125], but develop
a complex phenotype with skeletal and cardiac myopathies (Table 1). Cardiovascular defects occur in adult mice
whereby the microvasculature displays luminal narrowing due to EC folding and swelling [125], with increased vas-
cular permeability and capillary rupture (Table 1).
It is therefore clear that various BM components contribute to multiple aspects of cardiac development such as
laminin and collagen which have influence on cardiomyocyte differentiation and microvascular structure. However,
there are also defects which are unique to individual components, for example TGA in perlecan null mice relating
to issues with outflow tract development [127]. It is yet to be understood what phenotypes result from general BM
defects and which are due to impaired function of individual components. Future work could shed light on this by
employing new cardiac-specific knockout models that negate any systemic effects associated with the wide expression
pattern of BM components. These could also be used to disentangle roles in cardiac development versus adult heart
function, and their mechanistic basis.
Impact of BM disruption on the adult heart
Adult cardiovascular and cardiac diseases are the leading cause of death, place a significant burden on society, and
their global prevalence has doubled since 1990 to 523 million in 2019 [128]. Increased understanding of pathomolec-
ular disease mechanisms stands to underpin the development of novel treatment approaches. The ECM plays a critical
role in cardiac homeostasis and injury, whereby almost all attention is focused on the interstitial matrix [70]. In this
section, we review the roles of the BM within the adult heart as this remains under-explored. Specifically, we focus
on the contribution of the BM to cardiomyocyte function and how this is affected in various disease states. We have
broadly broken this down into three key aspects of adult cardiac function: mechanotransduction via BM interactions
with the cardiomyocyte, systolic and diastolic function, and finally ion transport and cardiac rhythm.
Mechanotransduction via BM interactions with the cardiomyocyte
The composition and arrangement of the interstitial ECM is closely related to the mechanical properties of the heart.
However, what is less well understood is how the composition and remodelling of the BM may influence the way car-
diomyocytes are subjected to and respond to mechanical stress [127,129]. This stress activates signalling cascades in
the cardiomyocyte, which in turn regulate the production of both interstitial ECM and BM components in a recipro-
cal nature (Figure 3) [130,131]. Ultrastructural analysis of failing hearts revealed that BM remodelling contributed to
disease progression with disruption in myocyte tethering, ultimately leading to the inability to withstand increased af-
terload and mechanical stretch [132]. Reducing the mechanical strain on the heart through left ventricular assistance
device saw a restoration in BM organisation and improved clinical outcomes for patients [133]. Together, these studies
highlight the importance of the preservation of BM structure and myocardial stability. The BM provides this stability
via interactions with several BM receptors present on the cardiomyocyte sarcolemma; integrins, dystroglycans, and
discoidin domain receptors 1/2 (DDR1 and DDR2) (Figure 3).
Integrins are heterodimeric transmembrane glycoproteins comprising an α and β subunit (Figure 3) [134]. Upon
binding with BM ligands such as collagen IV and laminin, integrin receptors cluster allowing for ‘outside-in’ sig-
nalling, which results in the interaction with cytoplasmic signalling and adapter proteins such as integrin linked
kinase, focal adhesion kinase, paxillin, and talin [135,136]. Cardiomyocytes highly express integrins α7β1, α5β1,
and α1β1, and to a lesser degree integrin α3, α6, α7, α9, and α10 [137]. Integrin receptors in striated muscle mainly
localise to costameres, which are submembranous complexes that stabilise the link between the ECM and the car-
diomyocyte sarcolemma at the sarcomeric z-line, and to the intercalated disks [138–140]. In the adult heart, integrins
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Figure 3. Influence of mechanical stress on BM composition and remodelling
Mechanical strain on the heart is sensed by three major BM receptors present on the cardiomyocyte sarcolemma, DDR1/2, integrins,
and dystroglycan receptors. These receptors are activated by interaction with various BM components, which results in intracellular
signalling cascades. These can have a pro-fibrotic/hypertrophic influence on cardiac fibroblasts that undergo a phenotypic switch
to a myofibroblast. In this state, the myofibroblasts increase matrix production including BM components producing a reciprocal
feed–forward loop, which can become pathological leading to a fibrotic cardiac ECM and altered BM morphology. This impairment
in cardiomyocyte–BM interaction further leads to activation of pathological signalling within the heart ultimately resulting in impaired
mechanotransduction and cardiac function.
sense mechanical load on the ECM and convert it into an intracellular biochemical processes referred to as mechan-
otransduction [141] (Figure 3). The importance of integrin function in cardiac biology is further illustrated by the
association of perturbed integrin expression with cardiovascular disease states, such as cardiac hypertrophy, heart
failure, cardiac fibrosis, and contractile dysfunction [142–144]. Mutations affecting integrin interaction specifically
with laminin-α4 (LAMA4) and laminin-α2 (LAMA2) have been identified as a genetic basis for the development of
severe dilated cardiomyopathy, further emphasising the importance of cell–BM interactions in cardiac contractility
[145–148].
Dystroglycans are the major non-integrin BM receptor on the cardiomyocyte cell membrane. They comprise an
α and β dystroglycan domains, where α-dystroglycan is situated entirely within the ECM and serves as a laminin
receptor [149,150] (Figure 3). β-dystroglycan is a transmembrane protein that interacts with α-dystroglycan and cy-
toskeletal proteins to form an adhesion complex with dystrophin and proteins such as dystrobrevin and syntrophin
to stabilise the myocyte sarcolemma [151,152]. Dystroglycan-deficient mice are embryonic lethal with disruption to
laminin and collagen IV deposition in Reichert’s membrane [153]. Further support for a role in BM assembly also
comes from defective laminin and collagen IV deposition in dystroglycan-deficient embryoid bodies [154]. However,
this BM disruption had no effect on cardiomyocyte differentiation within the embryoid bodies. Large myd mice are
a model of congenital muscular dystrophy type 1D in which incomplete glycosylation of α-dystroglycan reduces its
ability to bind laminin [155]. This is associated with focal myocardial damage, fibrosis, increased membrane perme-
ability and elevated susceptibility to mechanical load stress [156]. As reduced glycosylation does not affect laminin
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deposition this supports that dystroglycan-laminin binding is critical for maintaining sarcolemma stability against
mechanical strain [156].
DDR1/2 receptors are a class of non-integrin tyrosine kinase receptors which have extracellular ligands, specifically
collagens (Figure 3) [157–159]. Both DDRs are activated by fibrillar collagens (types I, II, III, and V), however DDR1
also binds collagen IV, a property not shared by the DDR2 receptor which is mainly activated by collagen type X
[159,160]. Upon binding of these collagens, the receptors become activated due to tyrosine autophosphorylation
[161]. DDRs have been implicated in several diseases including cancer, atherosclerosis, and arthritis [159] and due to
their influence over collagen fibrillogenesis and matrix remodelling, DDRs are key targets for several fibrotic disorders
[162]. For example, DDR1 drives fibrosis in renal injury and can also be translocated to the nucleus to drive collagen
IV expression [163]. This is also of interest in the heart as DDRs are markers of cardiac fibroblast activation [164]. In
addition, DDR blockade increased murine-derived cardiac fibroblast differentiation and fibrotic lesion development
post-myocardial infarction [165]. Interestingly, DDR2 knockout mouse revealed reduced heart mass, cardiomyocyte
length, altered myocardial collagen deposition and cross-linking, as well as a reduced rate of collagen synthesis by
cardiac fibroblasts [166]. DDR2 deficiency in mice also affected cardiac function with reduced cardiac contractility
and rate of relaxation in response to ionotropic stimulation, mimicking increased cardiac stress [166]. Together, these
data illustrate the importance of DDRs to normal cardiac function and matrix remodelling following cardiac injury.
Combined, the complex interactions of BM components with each other and with cell receptors, provide a mechanism
by which the BM modulates intracellular and extracellular processes that are at the basis of cardiac development and
pathophysiology associated with focal myocardial damage, fibrosis, increased membrane permeability and elevated
susceptibility to mechanical load stress [167] (Figures 1B and 3).
Systolic and diastolic ventricular function
Given the contribution of the BM to the structural stability of the heart, we can begin to appreciate how impairments
in the relationship between cardiomyocytes and the BM can be a feature in congenital and adult cardiac diseases. Heart
failure is characterised by left ventricular insufficiency either due to a failure of the myocardium to contract (systolic
dysfunction) or relax (diastolic dysfunction). Despite similar clinical presentations, systolic and diastolic dysfunc-
tion arise through different remodelling processes of the left ventricle [168]. BM components interact dynamically
with transmembrane integrin receptors on cardiomyocytes, and the matrix–cell transduction of biomechanical stress
causes hypertrophy via intracellular pathways such as melusin mediated AKT, GSK3β, and ERK1/2 signalling (Figure
3) [169]. Systolic dysfunction, or heart failure with reduced ejection fraction (EF), results from the reduced capacity of
the left ventricle to contract and the ventricle wall becomes dilated. In this case, the collagen network becomes com-
promised by matrix metalloproteinase (MMP) degradation, leading to a decrease in the number of cardiomyocytes
[170,171]. In systolic dysfunction, MMP expression is increased and results in the reduction in cross-links between
collagen molecules [172]. Support also comes from a Drosophila model with advanced cardiac ageing in which BM
thickness and expression of BM components such as laminin is increased with a reduction in lifespan and fractional
shortening (FS), indicating systolic dysfunction and impaired contractility [173].
Functional analysis of Col15−/− mice identified the first impaired heart contractility due to deficiency of a BM
component [125,174]. Interestingly, echocardiography revealed 1-month-old Col15a1−/− mice have a reduction in EF
and FS indicative of systolic dysfunction [174]. With age these functional impairments disappear despite a persistence
of morphological disorganisation of the cardiomyocytes. Interestingly, analysis of cardiac function in isolated hearts
of older Col15a1−/− mice uncovered a marked reduction in left ventricular pressure in response to isoproterenol
which pharmacologically increases heart rate. This indicates a decreased cardiac response following β-adrenergic
stimulation, a feature which is associated with congestive heart failure and ageing [125,175,176]. These complex car-
diac and microvasculature phenotypes in Col15a1−/− mice established that BM components are required for heart
contractility and the maintenance of contractile function throughout life.
This is similarly reflected in patients with COL6A1 mutations. Mutations in collagen VI result in two
muscle-related disorders; Bethlem myopathy and Ullrich congenital muscular dystrophy (UCMD) [177]. Bethlem
myopathy is characterised by progressive skeletal muscle weakness and joint contractures [178]. UCMD has simi-
lar features to Bethlem myopathy however, the disease is often more severe and earlier in onset [179]. It is currently
thought that there is no significant cardiac component in Bethlem myopathy and UCMD [180]. However, intriguingly,
progressive left ventricular dysfunction was noted in a patient diagnosed with Bethlem myopathy during pregnancy,
raising potential implications for early delivery [181], and perhaps suggesting that collagen VI mutations may impact
the ability of the heart to cope with the extra stress and workload in a progressive degenerative manner. The role of
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collagen type VI in myocardial infarction and cardiac function has also been explored in the Col6a1−/− mouse. In-
terestingly, following cardiac injury, adverse remodelling was reduced in knock-out animals suggesting collagen type
VI contributes to the initial injury response [182].
Diastolic heart failure, or heart failure with preserved EF, differs from systolic dysfunction as the myocardium can-
not relax efficiently leading to an increase in end diastolic pressure. Unlike systolic heart failure, diastolic heart failure
often occurs when the ventricular wall is thickened as the cardiomyocytes undergo hypertrophy. However, diastolic
dysfunction can also arise from other aetiologies including restrictive cardiomyopathy, constrictive pericarditis, and
tension pneumothorax. In addition, the interstitial ECM undergoes remodelling as the production of fibrillar colla-
gens (chiefly collagens I and III) increases, which is traditionally what is referred to when describing adverse ECM
remodelling. Interestingly, and less frequently discussed, is that the expression of BM components such as collagen IV,
laminin and fibronectin are also increased which contributes to the development of myocardial fibrosis and contrac-
tile dysfunction [183]. Models of prolonged supraventricular tachycardia (SVT) in pig hearts allowed for assessment
of how cardiomyocytes, their BM and interstitial ECM respond to increased mechanical strain. SVT is an abnormally
fast heart rhythm from which the source of improper electrical activity arises from the atria that results in reduced
cardiomyocyte contractility and decreased ventricular filling time [184]. The anchorage of the cardiomyocytes to the
BM is impaired as the sarcolemma fails to make complete contact with the interstitial ECM [185]. Following chronic
SVT, the connection between interstitial collagen and the BM are weakened [186]. In addition, cardiomyocytes in
systolic heart failure ‘slip’ due to reduced sarcolemma attachment to BM components which no longer provide struc-
tural support to the cardiomyocytes. The cardiomyocytes also become elongated, suggesting that the BM may play
a role in maintaining correct cellular dimensions of the cardiomyocytes when under mechanical stress [185]. At the
gross anatomical level this systolic dysfunction causes the left ventricular wall of these animals to dilate and to be-
come much thinner and prone to rupture, meaning these hearts do not have the capacity to contract and cope with
increased systolic pressures [187].
Ion transport and cardiac rhythm
Cardiac arrhythmias have been reported in several cases where patients have mutations affecting BM components
including COL4A1, COL6A1, and LAMA2 (Table 2) [99,119,188–191]. These findings indicate a potential link be-
tween BM disruption and the receptors that are involved in calcium transport and subsequent myofilament contrac-
tion. These receptors are structurally coupled to each other in an organisation called the cardiac dyad (Figure 4). This
dyad forms between t-tubules, an invagination of the sarcolemma that allows voltage gated calcium channels to sit
in close proximity to ryanodine receptors on the sarcoplasmic reticulum (Figure 4A) [192]. The cardiac dyad is nec-
essary for propagating action potentials and the contraction and relaxation of cardiomyocytes via calcium-induced
calcium release [193]. Unsurprisingly, disruption of t-tubule architecture is a pathological feature of heart failure
and is associated with impaired contractile function (Figure 4B) [194]. Interestingly, immunostaining of human my-
ocardium revealed that collagen IV is localised to t-tubule openings [195]. While this may suggest a role for the BM
and collagen IV in maintenance of the dyad and t-tubule structure, there has been no direct investigation of this. To
the best of our knowledge, the formation of the cardiac dyad and the maintenance of t-tubule architecture has not yet
been explored in a model of direct BM disruption.
The disorganisation of the cardiac dyad, in particular due to structural changes to the t-tubule, impairs regulation
of Ca2+ movement throughout the cardiomyocyte and has been implicated in the progression heart failure [196].
Defects in BM structure and composition could potentially affect the cardiac dyad structure which in turn mediates
β1 adrenoceptor signalling, inducing Ca2+ release [197]. Impaired calcium signalling due to interstitial ECM dis-
ruption occurs post myocardial infarction, hypertrophic cardiomyopathy and heart failure as excitation–contraction
coupling is lost [198,199]. Interestingly, recent work using siRNA mediated knockdown of Col4a2 showed that the
peptide canstatin, which is released by proteolytic cleavage of α2(IV), inhibits apoptosis of cardiomyocytes induced
by β1 adrenoceptor activation possibly by reducing excessive intracellular Ca2+ release by L-type Ca2+ channel [200].
Reduced COL4A2 levels also altered cardiac electrical activity and action potential [200]. While this indicates a link
between collagen IV, the BM and intracellular Ca2+ signalling, the mechanisms linking the L-type Ca2+ channel and
canstatin remain unclear [200]. Similarly, it also remains to be investigated if this is limited to canstatin as opposed
to uncleaved collagen IV.
Within the adult heart, the BM appears to play several important roles from providing mechanical support to
cardiomyocytes to assisting in excitation–contraction coupling. This has mainly been inferred from defects in BM
structure in cardiac pathologies in which contractility and electrical conduction become impaired. However, whether
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Figure 4. Structure of the cardiac dyad
(A) Overview of the structure of the t-tubule (pale yellow), BM, ECM and myofibril. (B) T-tubule and interaction between the sar-
colemma and the sarcoplasmic reticulum of the cardiomyocyte. In non-diseased states, the L-type voltage gated calcium channels
present on the sarcolemma are maintained in close proximity to the ryanodine receptors present on the terminal cisternae of the
sarcoplasmic reticulum. This mediates calcium release and induces contraction of the cardiomyocyte. In many common cardio-
vascular diseases, the t-tubule structure is compromised and can include elongation, distortion, and atrophy of the t-tubule. It
remains unclear how the relationship between with the BM is affected and if BM defects can lead to uncoupling of the cardiac dyad
ultimately leading to contractile dysfunction.
this reflects a functional role of the BM in these aspects, or the pathological remodelling of the BM could be conse-
quential and not a causal factor in these cardiac defects remains unknown. One main factor which has prevented the
mechanistic investigation of this link has been the lack of appropriate models of BM disruption, mostly due to the
embryonic lethality associated with BM component knock-out mouse models. Conditional mouse models as well as
animal models that recapitulate mutations seen in patients (Table 2) will be highly informative to identify the role of
the BM within the adult heart. This also extends to the use of zebrafish models which represent a powerful but so far
under-used model species to investigate the role of BM proteins in heart development and function.
Conclusions
There is now a large body of evidence highlighting how the BM and mutations in its individual components can cause
a spectrum of congenital heart defects in patients and animal models. Despite this and the growing evidence of BM
disruption and remodelling in various common cardiovascular pathologies, there are major unanswered questions
regarding the influence of BM defects on heart development, adult cardiac function and, importantly, the underlying
pathomolecular mechanisms of cardiac defects. Several studies discussed in this review have highlighted correlations
between the expression and deposition of BM components, and cardiac development and cardiomyocyte differentia-
tion. However, the difficulties associated with studying systemic knock-out models has made investigating the causal
relationship problematic. Refinement of animal models such as conditional mouse models and zebrafish will stand
to unlock the door towards understanding the role of the BM in cardiac biology and disease. For example, employing
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cardiac specific mouse knockout models of BM components would greatly accelerate the investigation of the func-
tional role of the BM, while overcoming the difficulties associated with BM disruption and embryo viability. Another
factor which has slowed progress in answering these questions is the lack of clinical association of cardiac defects with
disorders relating to BM components. Patients with mutations affecting BM components often receive limited evalu-
ation of cardiac function and/or the outcomes have not been reported. In patients where a cardiac defect is identified,
almost no mechanistic analysis is performed due to the obvious impracticality of obtaining cardiac tissue to carry out
this analysis. This again emphasises the need for well-designed in vivo models that appropriately recapitulate the hu-
man disease to shed light on the causal mechanisms. The continued and more intensive investigation of the influence
of the BM and ECM on cardiac development and function will be critical to gain a sufficient in depth understanding
of the fundamental biology to underpin the identification, design, and development of novel therapeutic targets for
several cardiovascular diseases.
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